CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 53 filers reported holding CATALYST BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,402 | +18800.0% | 7,052 | +13461.5% | 0.00% | – |
Q2 2023 | $18 | – | 52 | +2.0% | 0.00% | – |
Q1 2023 | $0 | – | 51 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 51 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 51 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 51 | -98.3% | 0.00% | – |
Q1 2022 | $2,000 | – | 3,082 | +6189.8% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 49 | -99.8% | 0.00% | – |
Q3 2021 | $128,000 | -65.2% | 31,107 | -63.4% | 0.00% | – |
Q2 2021 | $368,000 | -42.5% | 84,996 | -33.1% | 0.00% | – |
Q1 2021 | $640,000 | +21.0% | 126,971 | +51.5% | 0.00% | – |
Q4 2020 | $529,000 | +133.0% | 83,789 | +61.0% | 0.00% | – |
Q3 2020 | $227,000 | +65.7% | 52,046 | +121.8% | 0.00% | – |
Q2 2020 | $137,000 | +34.3% | 23,463 | +57.1% | 0.00% | – |
Q4 2019 | $102,000 | -87.1% | 14,939 | -90.7% | 0.00% | – |
Q3 2019 | $789,000 | -53.6% | 160,599 | -27.6% | 0.00% | – |
Q2 2019 | $1,701,000 | -8.2% | 221,735 | -2.9% | 0.00% | – |
Q1 2019 | $1,853,000 | +66.0% | 228,447 | +61.5% | 0.00% | – |
Q4 2018 | $1,116,000 | +56.3% | 141,460 | +113.7% | 0.00% | – |
Q3 2018 | $714,000 | +1883.3% | 66,196 | +2029.9% | 0.00% | – |
Q2 2018 | $36,000 | – | 3,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |